{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:35:59Z","timestamp":1790501759323,"version":"4.1.0"},"reference-count":143,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T00:00:00Z","timestamp":1580169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011022","name":"Vertex Pharmaceuticals","doi-asserted-by":"publisher","award":["VIA Award 2018"],"award-info":[{"award-number":["VIA Award 2018"]}],"id":[{"id":"10.13039\/100011022","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020","doi-asserted-by":"publisher","award":["MSCA-IF 707771 GENDER-CF"],"award-info":[{"award-number":["MSCA-IF 707771 GENDER-CF"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001448","name":"Alpha-1 Foundation","doi-asserted-by":"publisher","award":["Postdoctoral Fellowship 2019"],"award-info":[{"award-number":["Postdoctoral Fellowship 2019"]}],"id":[{"id":"10.13039\/100001448","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cystic fibrosis (CF) is an autosomal recessive genetic disorder arising from mutations to the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Disruption to normal ion homeostasis in the airway results in impaired mucociliary clearance, leaving the lung more vulnerable to recurrent and chronic bacterial infections. The CF lung endures an excess of neutrophilic inflammation, and whilst neutrophil serine proteases are a crucial part of the innate host defence to infection, a surplus of neutrophil elastase (NE) is understood to create a net destructive effect. Alpha-1 antitrypsin (A1AT) is a key antiprotease in the control of NE protease activity but is ineffective in the CF lung due to the huge imbalance of NE levels. Therapeutic strategies to boost levels of protective antiproteases such as A1AT in the lung remain an attractive research strategy to limit the damage from excess protease activity. microRNAs are small non-coding RNA molecules that bind specific cognate sequences to inhibit expression of target mRNAs. The inhibition of miRNAs which target the SERPINA1 (A1AT-encoding gene) mRNA represents a novel therapeutic approach for CF inflammation. This could involve the delivery of antagomirs that bind and sequester the target miRNA, or target site blockers that bind miRNA recognition elements within the target mRNA to prevent miRNA interaction. Therefore, miRNA targeted therapies offer an alternative strategy to drive endogenous A1AT production and thus supplement the antiprotease shield of the CF lung.<\/jats:p>","DOI":"10.3390\/ijms21030836","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T09:37:09Z","timestamp":1580204229000},"page":"836","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Alpha-1 Antitrypsin\u2014A Target for MicroRNA-Based Therapeutic Development for Cystic Fibrosis"],"prefix":"10.3390","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9263-0082","authenticated-orcid":false,"given":"Alison M.D.","family":"Hunt","sequence":"first","affiliation":[{"name":"Department of Clinical Microbiology, Royal College of Surgeons in Ireland, Dublin 9, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8331-7668","authenticated-orcid":false,"given":"Arlene M.A.","family":"Glasgow","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Royal College of Surgeons in Ireland, Dublin 9, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Humphreys","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Royal College of Surgeons in Ireland, Dublin 9, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2549-2569","authenticated-orcid":false,"given":"Catherine M.","family":"Greene","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology, Royal College of Surgeons in Ireland, Dublin 9, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,1,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.JAA.0000515540.36581.92","article-title":"Keep them breathing: Cystic fibrosis pathophysiology, diagnosis, 1286 and treatment","volume":"30","author":"Brown","year":"2017","journal-title":"Off. J. Am. Acad. Physician Assist."},{"key":"ref_2","unstructured":"Lechner, A.J., Matuschak, G.M., and Brink, D.S. (2015). Presentation and management of cystic fibrosis. Respiratory: An Integrated Approach to Disease, McGraw-Hill Education."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/0888-7543(91)90503-7","article-title":"Genomic DNA sequence of the cystic fibrosis transmembrane conductance regulator (cftr) gene","volume":"10","author":"Zielenski","year":"1991","journal-title":"Genomics"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.genom.6.080604.162122","article-title":"Evolution of the atp-binding cassette (abc) transporter superfamily in vertebrates","volume":"6","author":"Dean","year":"2005","journal-title":"Annu. Rev. Genom. Hum. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1146\/annurev.cb.08.110192.000435","article-title":"Abc transporters: From microorganisms to man","volume":"8","author":"Higgins","year":"1992","journal-title":"Annu. Rev. Cell Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1039\/B810471A","article-title":"Assessment of the cftr and enac association","volume":"5","author":"Berdiev","year":"2009","journal-title":"Mol. Biosyst."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"12397","DOI":"10.1038\/s41598-017-10910-0","article-title":"Epithelial chloride transport by cftr requires tmem16a","volume":"7","author":"Benedetto","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/thoraxjnl-2015-207588","article-title":"Airway surface liquid homeostasis in cystic fibrosis: Pathophysiology and therapeutic targets","volume":"71","author":"Haq","year":"2016","journal-title":"Thorax"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1183\/09059180.00008412","article-title":"Targeting a genetic defect: Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis","volume":"22","author":"Derichs","year":"2013","journal-title":"Eur. Respir. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S2213-2600(16)00023-0","article-title":"Progress in therapies for cystic fibrosis","volume":"4","author":"Amaral","year":"2016","journal-title":"Lancet Respir. Med."},{"key":"ref_11","unstructured":"Katkin, J.P. (2019, July 25). Cystic Fibrosis: Clinical Manifestations of Pulmonary Disease. UpToDate: 2019. Available online: https:\/\/www.uptodate.com\/contents\/cystic-fibrosis-clinical-manifestations-of-pulmonary-disease."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1164\/rccm.200304-505SO","article-title":"Pathophysiology and management of pulmonary infections in cystic fibrosis","volume":"168","author":"Gibson","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1513\/AnnalsATS.201306-159MG","article-title":"The cystic fibrosis lung microbiome","volume":"11","author":"Surette","year":"2014","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jaci.2009.12.980","article-title":"Overview of the immune response","volume":"125","author":"Chaplin","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ncb1456","article-title":"Cftr regulates phagosome acidification in macrophages and alters bactericidal activity","volume":"8","author":"Di","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"6990","DOI":"10.4049\/jimmunol.1100396","article-title":"Abnormal trafficking and degradation of tlr4 underlie the elevated inflammatory response in cystic fibrosis","volume":"186","author":"Bruscia","year":"2011","journal-title":"J. Immunol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbrc.2012.06.066","article-title":"Exaggerated inflammatory responses mediated by burkholderia cenocepacia in human macrophages derived from cystic fibrosis patients","volume":"424","author":"Kopp","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1159\/000446825","article-title":"Cystic fibrosis lung immunity: The role of the macrophage","volume":"8","author":"Bruscia","year":"2016","journal-title":"J. Innate Immun."},{"key":"ref_19","first-page":"819","article-title":"Interleukin 8 secretion from monocytes of subjects heterozygous for the deltaf508 cystic fibrosis transmembrane conductance regulator gene mutation is altered","volume":"11","author":"Zaman","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1164\/rccm.201510-1922OC","article-title":"Mutations of cystic fibrosis transmembrane conductance regulator gene cause a monocyte-selective adhesion deficiency","volume":"193","author":"Sorio","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Del Porto, P., Cifani, N., Guarnieri, S., Di Domenico, E.G., Mariggio, M.A., Spadaro, F., Guglietta, S., Anile, M., Venuta, F., and Quattrucci, S. (2011). Dysfunctional cftr alters the bactericidal activity of human macrophages against pseudomonas aeruginosa. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0019970"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.biocel.2007.11.008","article-title":"Neutrophil serine proteases fine-tune the inflammatory response","volume":"40","author":"Pham","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.4103\/2153-3539.109883","article-title":"Scalable system for classification of white blood cells from leishman stained blood stain images","volume":"4","author":"Mathur","year":"2013","journal-title":"J. Pathol. Inform."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.micinf.2003.09.008","article-title":"Neutrophil granules and secretory vesicles in inflammation","volume":"5","author":"Faurschou","year":"2003","journal-title":"Microbes Infect."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1053\/gast.2002.30348","article-title":"Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat","volume":"122","author":"Keck","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/MOH.0000000000000009","article-title":"The role of neutrophils in cystic fibrosis","volume":"21","author":"Gifford","year":"2014","journal-title":"Curr. Opin. Hematol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1501200","DOI":"10.1183\/13993003.01200-2015","article-title":"Protean proteases: At the cutting edge of lung diseases","volume":"49","author":"Taggart","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/j.1476-5381.2009.00448.x","article-title":"Proteases and antiproteases in chronic neutrophilic lung disease \u2013 relevance to drug discovery","volume":"158","author":"Greene","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"L1189","DOI":"10.1152\/ajplung.00028.2015","article-title":"Respiratory protease\/antiprotease balance determines susceptibility to viral infection and can be modified by nutritional antioxidants","volume":"308","author":"Meyer","year":"2015","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"293053","DOI":"10.1155\/2015\/293053","article-title":"The role of serine proteases and antiproteases in the cystic fibrosis lung","volume":"2015","author":"Twigg","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"8215","DOI":"10.1073\/pnas.89.17.8215","article-title":"Three human elastase-like genes coordinately expressed in the myelomonocyte lineage are organized as a single genetic locus on 19pter","volume":"89","author":"Zimmer","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"16171","DOI":"10.1021\/bi00049a032","article-title":"Nonisotropic enzyme--inhibitor interactions: A novel nonoxidative mechanism for quantum proteolysis by human neutrophils","volume":"34","author":"Liou","year":"1995","journal-title":"Biochemistry"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/oxfordjournals.jbchem.a123277","article-title":"Human neutrophil elastase: Degradation of basement membrane components and immunolocalization in the tissue","volume":"108","author":"Watanabe","year":"1990","journal-title":"J. Biochem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.molmed.2008.08.001","article-title":"Factor xa: At the crossroads between coagulation and signaling in physiology and disease","volume":"14","author":"Borensztajn","year":"2008","journal-title":"Trends Mol. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.bbadis.2012.12.013","article-title":"Coagulation and coagulation signalling in fibrosis","volume":"1832","author":"Mercer","year":"2013","journal-title":"Biochim. Biophys. Acta (BBA)\u2013Mol. Basis Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-5793(03)00482-4","article-title":"Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4","volume":"544","author":"Devaney","year":"2003","journal-title":"FEBS Lett."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"35494","DOI":"10.1074\/jbc.M103543200","article-title":"Interleukin-8 up-regulation by neutrophil elastase is mediated by myd88\/irak\/traf-6 in human bronchial epithelium","volume":"276","author":"Walsh","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1182\/blood.V100.5.1860.h81702001860_1860_1868","article-title":"Role of toll-like receptor 2 (tlr2) in neutrophil activation: Gm-csf enhances tlr2 expression and tlr2-mediated interleukin 8 responses in neutrophils","volume":"100","author":"Mandell","year":"2002","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1517\/14728222.12.2.145","article-title":"Targeting neutrophil elastase in cystic fibrosis","volume":"12","author":"Kelly","year":"2008","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/thx.2006.062190","article-title":"A morphometric study of mucins and small airway plugging in cystic fibrosis","volume":"62","author":"Burgel","year":"2007","journal-title":"Thorax"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"L671","DOI":"10.1152\/ajplung.00220.2002","article-title":"Neutrophil elastase increases muc4 expression in normal human bronchial epithelial cells","volume":"284","author":"Fischer","year":"2003","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"L355","DOI":"10.1152\/ajplung.00040.2005","article-title":"Neutrophil elastase stimulates muc1 gene expression through increased sp1 binding to the muc1 promoter","volume":"289","author":"Kuwahara","year":"2005","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/rccm.201605-1027OC","article-title":"Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis","volume":"195","author":"Chalmers","year":"2017","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nm0598-615","article-title":"Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis","volume":"4","author":"Belaaouaj","year":"1998","journal-title":"Nat. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1083\/jcb.201006052","article-title":"Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps","volume":"191","author":"Papayannopoulos","year":"2010","journal-title":"J. Cell Biol."},{"key":"ref_47","first-page":"509","article-title":"Neutrophil serine proteinases cleave bacterial flagellin, abrogating its host response-inducing activity","volume":"172","author":"Espinola","year":"2004","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1128\/IAI.00922-06","article-title":"Neutrophil elastase, an innate immunity effector molecule, represses flagellin transcription in pseudomonas aeruginosa","volume":"74","author":"Sonawane","year":"2006","journal-title":"Infect. Immun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1172\/JCI114699","article-title":"Neutrophil elastase cleaves c3bi on opsonized pseudomonas as well as cr1 on neutrophils to create a functionally important opsonin receptor mismatch","volume":"86","author":"Tosi","year":"1990","journal-title":"J. Clin. Investig."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.4049\/jimmunol.1301920","article-title":"Mechanism of neutrophil dysfunction: Neutrophil serine proteases cleave and inactivate the c5a receptor","volume":"192","author":"Tambourgi","year":"2014","journal-title":"J. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1172\/JCI0213572","article-title":"Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis","volume":"109","author":"Vandivier","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1086\/423821","article-title":"Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis","volume":"190","author":"Rogan","year":"2004","journal-title":"J. Infect. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0014-5793(03)00577-5","article-title":"Neutrophil elastase up-regulates human beta-defensin-2 expression in human bronchial epithelial cells","volume":"546","author":"Griffin","year":"2003","journal-title":"FEBS Lett."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.4049\/jimmunol.154.9.4842","article-title":"Cleavage of lymphocyte surface antigens cd2, cd4, and cd8 by polymorphonuclear leukocyte elastase and cathepsin g in patients with cystic fibrosis","volume":"154","author":"Doring","year":"1995","journal-title":"J. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1172\/JCI5779","article-title":"Proteolysis of monocyte cd14 by human leukocyte elastase inhibits lipopolysaccharide-mediated cell activation","volume":"103","author":"Balloy","year":"1999","journal-title":"J. Clin. Investig."},{"key":"ref_56","first-page":"S39","article-title":"Inflammation and its genesis in cystic fibrosis","volume":"40","author":"Nichols","year":"2015","journal-title":"Pediatric Pulmonol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jcf.2015.03.003","article-title":"Inflammation in cystic fibrosis lung disease: Pathogenesis and therapy","volume":"14","author":"Cantin","year":"2015","journal-title":"J. Cyst. Fibros: Off. J. Eur. Cyst. Fibros. Soc."},{"key":"ref_58","first-page":"S191","article-title":"Alpha-1 antitrypsin therapy in cystic fibrosis and the lung disease associated with alpha-1 antitrypsin deficiency","volume":"13","author":"McElvaney","year":"2016","journal-title":"Ann. Am. Thorac. Soc."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1183\/09031936.93.04010040","article-title":"Proteolytic inactivation of alpha 1-proteinase inhibitor in infected bronchial secretions from patients with cystic fibrosis","volume":"4","author":"Suter","year":"1991","journal-title":"Eur. Respir. J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"8148","DOI":"10.4049\/jimmunol.0901716","article-title":"Decreased levels of secretory leucoprotease inhibitor in the pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation","volume":"183","author":"Weldon","year":"2009","journal-title":"J. Immunol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"32377","DOI":"10.1074\/jbc.M803707200","article-title":"Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis","volume":"283","author":"Guyot","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1165\/ajrcmb\/8.4.439","article-title":"Characterization and gene sequence of the precursor of elafin, an elastase-specific inhibitor in bronchial secretions","volume":"8","author":"Sallenave","year":"1993","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"14791","DOI":"10.1016\/S0021-9258(18)77182-2","article-title":"Elafin: An elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence","volume":"265","author":"Wiedow","year":"1990","journal-title":"J. Biol. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1152\/physiolgenomics.00289.2004","article-title":"Transcriptional response of bronchial epithelial cells to pseudomonas aeruginosa: Identification of early mediators of host defense","volume":"21","author":"Vos","year":"2005","journal-title":"Physiol. Genom."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1165\/ajrcmb.11.6.7946401","article-title":"Regulation of secretory leukocyte proteinase inhibitor (slpi) and elastase-specific inhibitor (esi\/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes","volume":"11","author":"Sallenave","year":"1994","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0014-5793(99)01004-2","article-title":"Human neutrophil elastase regulates the expression and secretion of elafin (elastase-specific inhibitor) in type ii alveolar epithelial cells","volume":"457","author":"Reid","year":"1999","journal-title":"FEBS Lett."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jlb.61.6.695","article-title":"Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils","volume":"61","author":"Sallenave","year":"1997","journal-title":"J. Leukoc. Biol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1515\/znc-2001-3-420","article-title":"Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor","volume":"56","author":"Mihaila","year":"2001","journal-title":"Zeitschrift fur Naturforschung. C J. Biosci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1021\/bi00058a021","article-title":"Kinetics of the inhibition of human leukocyte elastase by elafin, a 6-kilodalton elastase-specific inhibitor from human skin","volume":"32","author":"Ying","year":"1993","journal-title":"Biochemistry"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1165\/ajrcmb.24.1.4300","article-title":"Kinetics of the inhibition of proteinase 3 by elafin","volume":"24","author":"Ying","year":"2001","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0014-5793(99)00670-5","article-title":"Elafin (elastase-specific inhibitor) has anti-microbial activity against gram-positive and gram-negative respiratory pathogens","volume":"452","author":"Simpson","year":"1999","journal-title":"FEBS Lett."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1111\/j.1742-4658.2008.06355.x","article-title":"The antibacterial and antifungal properties of trappin-2 (pre-elafin) do not depend on its protease inhibitory function","volume":"275","author":"Baranger","year":"2008","journal-title":"FEBS J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2567.2009.03165.x","article-title":"Trappin-2\/elafin: A novel innate anti-human immunodeficiency virus-1 molecule of the human female reproductive tract","volume":"129","author":"Ghosh","year":"2010","journal-title":"Immunology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"34730","DOI":"10.1074\/jbc.M604844200","article-title":"Elafin prevents lipopolysaccharide-induced ap-1 and nf-kappab activation via an effect on the ubiquitin-proteasome pathway","volume":"281","author":"Butler","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_75","unstructured":"McElvaney, N.G., and Crystal, R.G. (1997). The Lung, Lipincott-Raven."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0014-5793(86)81220-0","article-title":"The acid-stable proteinase inhibitor of human mucous secretions (husi-i, antileukoprotease). Complete amino acid sequence as revealed by protein and cdna sequencing and structural homology to whey proteins and red sea turtle proteinase inhibitor","volume":"199","author":"Seemuller","year":"1986","journal-title":"FEBS Lett."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1128\/IAI.73.3.1271-1274.2005","article-title":"Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor","volume":"73","author":"Doumas","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1042\/bst0300116","article-title":"Novel roles of protease inhibitors in infection and inflammation","volume":"30","author":"Hiemstra","year":"2002","journal-title":"Biochem. Soc. Trans."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1084\/jem.20050768","article-title":"Secretory leucoprotease inhibitor binds to nf-kappab binding sites in monocytes and inhibits p65 binding","volume":"202","author":"Taggart","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0002-9440(10)65270-4","article-title":"Inhibition of nf-kappab activation and augmentation of ikappabbeta by secretory leukocyte protease inhibitor during lung inflammation","volume":"154","author":"Lentsch","year":"1999","journal-title":"Am. J. Pathol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"33648","DOI":"10.1074\/jbc.M203710200","article-title":"Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced ikappabalpha degradation without affecting phosphorylation or ubiquitination","volume":"277","author":"Taggart","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.4049\/jimmunol.0802864","article-title":"Evidence for unfolded protein response activation in monocytes from individuals with alpha-1 antitrypsin deficiency","volume":"184","author":"Carroll","year":"2010","journal-title":"J. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm1690","article-title":"Cleavage of cxcr1 on neutrophils disables bacterial killing in cystic fibrosis lung disease","volume":"13","author":"Hartl","year":"2007","journal-title":"Nat. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4137\/BMI.S1115","article-title":"Low serum alpha-1 antitrypsin (aat) in family members of individuals with autism correlates with pimz genotype","volume":"4","author":"Russo","year":"2009","journal-title":"Biomark Insights"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12967-017-1193-9","article-title":"Cystic fibrosis: Current therapeutic targets and future approaches","volume":"15","author":"Rafeeq","year":"2017","journal-title":"J. Transl. Med."},{"key":"ref_86","unstructured":"Simon, R.H. (2019, July 25). Cystic fibrosis: Overview of the Treatment of Lung Disease. UpToDate: 2019. Available online: https:\/\/www.uptodate.com\/contents\/cystic-fibrosis-overview-of-the-treatment-of-lung-disease."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1164\/rccm.201906-1190PP","article-title":"Targeting proteases in cystic fibrosis lung disease. Paradigms, progress, and potential","volume":"201","author":"McKelvey","year":"2020","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1183\/09031936.00047306","article-title":"Alpha1-antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients","volume":"29","author":"Griese","year":"2007","journal-title":"Eur. Respir. J."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ppul.20345","article-title":"Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis","volume":"41","author":"Martin","year":"2006","journal-title":"Pediatric Pulmonol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/ppul.20167","article-title":"Aerosol treatment with mnei suppresses bacterial proliferation in a model of chronic pseudomonas aeruginosa lung infection","volume":"39","author":"Woods","year":"2005","journal-title":"Pediatric Pulmonol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"261s","DOI":"10.1378\/chest.110.6_Supplement.261S","article-title":"Use of secretory leukoprotease inhibitor to augment lung antineutrophil elastase activity","volume":"110","author":"Vogelmeier","year":"1996","journal-title":"Chest"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI115994","article-title":"Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor","volume":"90","author":"McElvaney","year":"1992","journal-title":"J. Clin. Investig."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/mt.2014.162","article-title":"A functional variant of elafin with improved anti-inflammatory activity for pulmonary inflammation","volume":"23","author":"Small","year":"2015","journal-title":"Mol. Ther."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/mi.2015.90","article-title":"A secretory leukocyte protease inhibitor variant with improved activity against lung infection","volume":"9","author":"Camper","year":"2016","journal-title":"Mucosal Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.chest.2017.03.056","article-title":"The role of neutrophil elastase inhibitors in lung diseases","volume":"152","author":"Polverino","year":"2017","journal-title":"Chest"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jcf.2012.02.003","article-title":"Anti-inflammatory effects of dx-890, a human neutrophil elastase inhibitor","volume":"11","author":"Dunlevy","year":"2012","journal-title":"J. Cyst. Fibros."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcf.2015.10.008","article-title":"A small molecule neutrophil elastase inhibitor, krp-109, inhibits cystic fibrosis mucin degradation","volume":"15","author":"Chillappagari","year":"2016","journal-title":"J. Cyst. Fibros."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.pupt.2011.08.001","article-title":"In vivo efficacy of krp-109, a novel elastase inhibitor, in a murine model of severe pneumococcal pneumonia","volume":"24","author":"Yamada","year":"2011","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1183\/09031936.00194611","article-title":"Efficacy, safety and effect on biomarkers of azd9668 in cystic fibrosis","volume":"40","author":"Elborn","year":"2012","journal-title":"Eur. Respir. J."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"12480","DOI":"10.1074\/jbc.RA118.002644","article-title":"Molecular principles for heparin oligosaccharide-based inhibition of neutrophil elastase in cystic fibrosis","volume":"293","author":"Kummarapurugu","year":"2018","journal-title":"J. Biol. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"C97","DOI":"10.1152\/ajpcell.00009.2010","article-title":"Low anticoagulant heparin targets multiple sites of inflammation, suppresses heparin-induced thrombocytopenia, and inhibits interaction of rage with its ligands","volume":"299","author":"Rao","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1093\/glycob\/cww011","article-title":"N-arylacyl o-sulfonated aminoglycosides as novel inhibitors of human neutrophil elastase, cathepsin g and proteinase 3","volume":"26","author":"Craciun","year":"2016","journal-title":"Glycobiology"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Xu, X., Abdalla, T., Bratcher, P.E., Jackson, P.L., Sabbatini, G., Wells, J.M., Lou, X.Y., Quinn, R., Blalock, J.E., and Clancy, J.P. (2017). Doxycycline improves clinical outcomes during cystic fibrosis exacerbations. Eur. Respir. J., 49.","DOI":"10.1183\/13993003.01102-2016"},{"key":"ref_104","first-page":"201","article-title":"Prolastin aerosol therapy and sputum taurine in cystic fibrosis","volume":"29","author":"Cantin","year":"2006","journal-title":"Clin. Investig. Med. Med. Clin. Exp."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/hum.2015.044","article-title":"Challenges and prospects for alpha-1 antitrypsin deficiency gene therapy","volume":"26","author":"Wozniak","year":"2015","journal-title":"Hum.Gene Ther."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1073\/pnas.89.1.89","article-title":"Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes","volume":"89","author":"Kay","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of scid-x1","volume":"118","author":"Garrigue","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2217\/fvl.11.6","article-title":"Implications of the innate immune response to adenovirus and adenoviral vectors","volume":"6","author":"Gregory","year":"2011","journal-title":"Future Virol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"6877","DOI":"10.1093\/emboj\/20.23.6877","article-title":"Functional anatomy of sirnas for mediating efficient rnai in drosophila melanogaster embryo lysate","volume":"20","author":"Elbashir","year":"2001","journal-title":"EMBO J."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/mt.2011.292","article-title":"Sustained mirna-mediated knockdown of mutant aat with simultaneous augmentation of wild-type aat has minimal effect on global liver mirna profiles","volume":"20","author":"Mueller","year":"2012","journal-title":"Mol. Ther."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nrm2085","article-title":"Illuminating the silence: Understanding the structure and function of small rnas","volume":"8","author":"Rana","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"Micrornas: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"9667","DOI":"10.1073\/pnas.0703820104","article-title":"Target mrnas are repressed as efficiently by microrna-binding sites in the 5\u2019 utr as in the 3\u2019 utr","volume":"104","author":"Lytle","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","article-title":"The c. Elegans heterochronic gene lin-4 encodes small rnas with antisense complementarity to lin-14","volume":"75","author":"Lee","year":"1993","journal-title":"Cell"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"529642","DOI":"10.1155\/2015\/529642","article-title":"Microrna dysregulation in cystic fibrosis","volume":"2015","author":"McKiernan","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.arr.2010.08.002","article-title":"Microrna and aging: A novel modulator in regulating the aging network","volume":"9","author":"Chen","year":"2010","journal-title":"Ageing Res. Rev."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"e2706","DOI":"10.7717\/peerj.2706","article-title":"Microrna biogenesis pathway genes polymorphisms and cancer risk: A systematic review and meta-analysis","volume":"4","author":"He","year":"2016","journal-title":"PeerJ"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Wang, S., Wan, X., and Ruan, Q. (2016). The microrna-21 in autoimmune diseases. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17060864"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.4155\/fmc.14.116","article-title":"Mirna-based therapies: Strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents","volume":"6","author":"Baumann","year":"2014","journal-title":"Future Med. Chem."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-907X-3-1","article-title":"Inhibition of microrna function by antimir oligonucleotides","volume":"3","author":"Stenvang","year":"2012","journal-title":"Silence"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1042\/BJ20110672","article-title":"Microrna regulation of expression of the cystic fibrosis transmembrane conductance regulator gene","volume":"438","author":"Gillen","year":"2011","journal-title":"Biochem. J."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.4049\/jimmunol.1202960","article-title":"Regulation of cystic fibrosis transmembrane conductance regulator by microrna-145, -223, and -494 is altered in deltaf508 cystic fibrosis airway epithelium","volume":"190","author":"Oglesby","year":"2013","journal-title":"J. Immunol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1165\/rcmb.2012-0430OC","article-title":"Post-transcriptional regulation of cystic fibrosis transmembrane conductance regulator expression and function by micrornas","volume":"49","author":"Ramachandran","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Amato, F., Seia, M., Giordano, S., Elce, A., Zarrilli, F., Castaldo, G., and Tomaiuolo, R. (2013). Gene mutation in microrna target sites of cftr gene: A novel pathogenetic mechanism in cystic fibrosis?. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060448"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"13362","DOI":"10.1073\/pnas.1210906109","article-title":"A microrna network regulates expression and biosynthesis of wild-type and deltaf508 mutant cystic fibrosis transmembrane conductance regulator","volume":"109","author":"Ramachandran","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/j.bbadis.2013.09.012","article-title":"Anoctamin 1 dysregulation alters bronchial epithelial repair in cystic fibrosis","volume":"1832","author":"Ruffin","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41467-017-00813-z","article-title":"Microrna-9 downregulates the ano1 chloride channel and contributes to cystic fibrosis lung pathology","volume":"8","author":"Sonneville","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.4049\/jimmunol.0902669","article-title":"Mir-126 is downregulated in cystic fibrosis airway epithelial cells and regulates tom1 expression","volume":"184","author":"Oglesby","year":"2010","journal-title":"J. Immunol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1038\/ncomms7221","article-title":"Pharmacological modulation of the akt\/microrna-199a-5p\/cav1 pathway ameliorates cystic fibrosis lung hyper-inflammation","volume":"6","author":"Zhang","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1183\/09031936.00163414","article-title":"Mir-17 overexpression in cystic fibrosis airway epithelial cells decreases interleukin-8 production","volume":"46","author":"Oglesby","year":"2015","journal-title":"Eur. Respir. J."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1165\/rcmb.2013-0160OC","article-title":"Expression of microrna-93 and interleukin-8 during pseudomonas aeruginosa-mediated induction of proinflammatory responses","volume":"50","author":"Fabbri","year":"2014","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"11604","DOI":"10.1074\/jbc.M110.198390","article-title":"Elevated mir-155 promotes inflammation in cystic fibrosis by driving hyperexpression of interleukin-8","volume":"286","author":"Bhattacharyya","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"16259","DOI":"10.1038\/s41598-019-52770-w","article-title":"Mir-146a is over-expressed and controls il-6 production in cystic fibrosis macrophages","volume":"9","author":"Luly","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1080\/15548627.2016.1217370","article-title":"Elevated mirc1\/mir17-92 cluster expression negatively regulates autophagy and cftr (cystic fibrosis transmembrane conductance regulator) function in cf macrophages","volume":"12","author":"Tazi","year":"2016","journal-title":"Autophagy"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"13519","DOI":"10.1038\/s41598-017-14055-y","article-title":"Microrna-181b is increased in cystic fibrosis cells and impairs lipoxin a4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense","volume":"7","author":"Pierdomenico","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/15476286.2016.1197484","article-title":"Rptor, a novel target of mir-155, elicits a fibrotic phenotype of cystic fibrosis lung epithelium by upregulating ctgf","volume":"13","author":"Tsuchiya","year":"2016","journal-title":"RNA Biol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1164\/rccm.201311-1986OC","article-title":"Mir-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin s production","volume":"190","author":"Weldon","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40348-014-0012-0","article-title":"Mirna-221 is elevated in cystic fibrosis airway epithelial cells and regulates expression of atf6","volume":"2","author":"Oglesby","year":"2015","journal-title":"Mol. Cell. Pediatrics"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1042\/BST20170469","article-title":"Non-coding rna in cystic fibrosis","volume":"46","author":"Glasgow","year":"2018","journal-title":"Biochem. Soc. Trans."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.omtn.2019.09.007","article-title":"Aberrant micrornaomics in pulmonary complications: Implications in lung health and diseases","volume":"18","author":"Dutta","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1586\/eri.11.175","article-title":"Therapeutic modulation of mirna for the treatment of proinflammatory lung diseases","volume":"10","author":"Hassan","year":"2012","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S1470-2045(17)30621-6","article-title":"Safety and activity of microrna-loaded minicells in patients with recurrent malignant pleural mesothelioma: A first-in-man, phase 1, open-label, dose-escalation study","volume":"18","author":"Pavlakis","year":"2017","journal-title":"Lancet. Oncol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1093\/nar\/gks1466","article-title":"Isolation and identification of cell-specific micrornas targeting a messenger rna using a biotinylated anti-sense oligonucleotide capture affinity technique","volume":"41","author":"Hassan","year":"2013","journal-title":"Nucleic Acids Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/3\/836\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:44:46Z","timestamp":1760363086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/3\/836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,28]]},"references-count":143,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,2]]}},"alternative-id":["ijms21030836"],"URL":"https:\/\/doi.org\/10.3390\/ijms21030836","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,28]]}}}